Use of Kidney Donors with Hepatitis B, Hepatitis C, or Brain Tumor: A Single-Center Experience

Tatar E., Turan M. N. , Firat O. , Sezer T. O. , Sozbilen M., Solak I., ...Daha Fazla

TRANSPLANTATION PROCEEDINGS, cilt.44, ss.1601-1603, 2012 (SCI İndekslerine Giren Dergi) identifier identifier identifier


Introduction. With the rapid increase in the number of patients on the waiting lists, the idea of using organs from donors who were previously classified as "marginal" has emerged. The aim of this study was to evaluate the clinical outcomes of the patients who received kidneys from donors with hepatitis B, hepatitis C, or brain tumors.